Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 13 Breast Neoplasms 10 Polycystic Ovary Syndrome 8 Obesity 8 Colorectal Neoplasms 8 Weight Loss 6 Neoplasms 6 Prostatic Neoplasms 5 Colonic Neoplasms 5 Multiple Endocrine Neoplasia Type 1 3 Endometrial Neoplasms 3 Recurrence 2 Pancreatic Neoplasms 2 Overweight 2 Ovarian Neoplasms 2 Malnutrition 2 Lymphoma, Follicular 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Body Weight Changes 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Smoking 1 Sexual Dysfunction, Physiological 1

Interventions

Temozolomide 264 Radiotherapy 119 Bevacizumab 105 Magnetic Resonance Spectroscopy 59 Radiation 47 pembrolizumab 30 Irinotecan 28 Surgical Procedures, Operative 23 Lomustine 21 Specimen Handling 19 Nivolumab 19 Radiosurgery 18 Carmustine 18 Aminolevulinic Acid 16 Erlotinib Hydrochloride 15 Drug Therapy 15 Blood Specimen Collection 14 Radiotherapy, Intensity-Modulated 13 O(6)-benzylguanine 13 Chemotherapy, Adjuvant 13 Carboplatin 13 Filgrastim 11 Cyclophosphamide 11 sargramostim 10 poly ICLC 10 atezolizumab 10 Thalidomide 10 Etoposide 10 Ipilimumab 9 Everolimus 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Diet × Clear all

NCT07553520 2026-04-28

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

UNC Lineberger Comprehensive Cancer Center

Phase NA Withdrawn

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡